domperidone has been researched along with vasoactive intestinal peptide in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mogg, RJ; Samson, WK | 1 |
Arey, BJ; Freeman, ME | 1 |
Dominguez, JR; López, FJ; Negro-Vilar, A; Sánchez-Franco, F | 1 |
Gala, RR; Haisenleder, DJ; Lawson, DM; Moy, JA | 2 |
Conti, A; Faglia, G; Muratori, M; Togni, E; Travaglini, P | 1 |
Abbott, CR; Bloom, SR; Ghatei, MA; Kim, MS; Morgan, DG; Murphy, KG; Russell, SH; Small, CJ; Taheri, S; Todd, JF | 1 |
7 other study(ies) available for domperidone and vasoactive intestinal peptide
Article | Year |
---|---|
Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
Topics: Animals; Domperidone; Dopamine; Dopamine Antagonists; Hypothalamus; Kinetics; Male; Neuropeptides; Oxytocin; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide | 1990 |
Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion.
Topics: Animals; Domperidone; Female; Fenclonine; Hypothalamus; Ovariectomy; Oxytocin; Periodicity; Prolactin; Rats; Rats, Inbred Strains; Serotonin; Vasoactive Intestinal Peptide | 1989 |
Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.
Topics: Animals; Domperidone; Dopamine; Haloperidol; Immunization, Passive; Male; Periodicity; Pimozide; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vasoactive Intestinal Peptide | 1989 |
The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Female; Hysterectomy; Prolactin; Pseudopregnancy; Rats; Thyrotropin-Releasing Hormone; Time Factors; Vasoactive Intestinal Peptide | 1986 |
The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Drug Synergism; Estradiol; Female; Ovariectomy; Progesterone; Prolactin; Rats; Rats, Inbred Strains; Sulpiride; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide | 1988 |
Vasoactive intestinal polypeptide and dopamine: effect on prolactin secretion in normal women and patients with microprolactinomas.
Topics: Adolescent; Adult; Domperidone; Dopamine; Female; Humans; Pituitary Neoplasms; Prolactin; Vasoactive Intestinal Peptide | 1987 |
Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
Topics: Animals; Carrier Proteins; Cells, Cultured; Corticotropin-Releasing Hormone; Domperidone; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Hypothalamus; In Vitro Techniques; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Luteinizing Hormone; Male; Neuropeptides; Neurotensin; Orexin Receptors; Orexins; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Somatostatin; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide | 2000 |